Jonathan Poole

DIRECTOR · ACADIA PHARMACEUTICALS INC · CIK 0001604689

FILING MIX · LIFETIME88%/12%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

Mar 2026

HOLDINGS NOW

2,010

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Jonathan Poole. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

ACAD · 2,010 shares · as of May 29, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 7 buys / 1 sellsCOVERAGE · 2 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
ACAD ACADIA PHARMACEUTICALS INC	PURCHASE	2,010	—	—	2,010	May 29, 2026	Jun 1, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	SALE	2,010	—	—	0	May 29, 2026	Jun 1, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	PURCHASEGRANT Stock grant	9,311	—	—	9,311	May 29, 2026	Jun 1, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	PURCHASEGRANT Stock grant	16,004	—	—	16,004	May 29, 2026	Jun 1, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	PURCHASEGRANT Stock grant	4,218	—	—	4,218	Mar 3, 2026	Mar 20, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	PURCHASEGRANT Stock grant	3,565	—	—	3,565	Mar 3, 2026	Mar 20, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	PURCHASEGRANT Stock grant	7,482	—	—	7,482	Mar 3, 2026	Mar 20, 2026 ↗	View →
ACAD ACADIA PHARMACEUTICALS INC	PURCHASEGRANT Stock grant	2,010	—	—	2,010	Mar 3, 2026	Mar 20, 2026 ↗	View →

Other insiders · ACAD

Loading peer insiders…

About this filer

CIK 0001604689

ROLE

Director

PRIMARY

ACAD

COMPANIES

ACTIVE SINCE

Mar 2026

MARKETPEEL · /INSIDER/0001604689DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.